Integrative Pharmacology, Toxicology and Genotoxicology

An Open Access, Peer Reviewed Journal
Impact-Factor: 0.00*
Online ISSN: 2058-8496

About Journal

Integrative Pharmacology, Toxicology and Genotoxicology

Online ISSN: 2058-8496

Integrative Pharmacology, Toxicology and Genotoxicology is being discontinued as of 2016 and will not accept any further submissions.

Marcelo L. Larramendy


Professor Dr. Marcelo L. Larramendy was born in La Plata, Argentina and obtained his Ph.D. at the Faculty of Natural Sciences and Museum from the National University of La Plata (UNLP), Argentina, in 1978. Appointed Member of the Research Career of the National Scientific and Technological Council of Scientific and Technical Research of Argentina (CONICET) in 1981, coating today as Senior Researcher. Since 1991, he serves as Professor of Molecular Cell Biology at the UNLP. Former Member of the Executive Committee of the Latin American Association of Environmental Mutagensis, Teratogenesis and Carcinogenesis (ALAMCTA). Author of more than 450 contributions in the field, including scientific publications, mostly in high impact and prestigious scientific journals, research communications and conferences worldwide. Lecturer at many conferences and courses worldwide. Recipient of several national and international awards including, among others, the "Bernardo Houssay 1987" and the "Diamond Cover Award 1992" granted by CONICET, Argentina and the American National Society for Histotechnology (USA). Prof. Dr. Larramendy is a regular Lecturer at the international A. Hollaender Courses organized by the International Association of the Environmental Society (IAEMS). He has carried out post-Doctoral research activities at the National Cancer Institute (NIH), Bethesda, USA and has been Guest Scientist at the Department of Medical Genetics at the University of Helsinki, Finland. Expert in Molecular Cytogenetics, Genetic Toxicology and Ecotoxicology. He is, or has been, referee for more than 20 international scientific journals including some of the top periodicals within his scope of work. Editor of five books in his field which have been widely acknowledged internationally. Presently, Prof. Dr. Larramendy is Head of the Laboratory of Molecular Cytogenetics and Genotoxicology at the UNLP, a multidisciplinary research team which includes researchers, research students and staff, keeping strong collaborative links with several Argentinean and international research groups as well as the industry.

Editorial Board.


Executive Editor


Ofelia A. OLIVERO

Senior Reseacher
National Cancer Institute
NIH, USA

Nicholas C. Popescu

Laboratory of Experimental Carcinogenesis
National Cancer Institute
NIH, USA

Diego Rua

Team Leader and Lead Biologist
U.S. Food & Drug Administration (FDA)
USA


Dorothy Colagiovanni

Senior Director of Toxicology
N30 Pharmaceuticals
USA

John Pierce Wise

Director and Professor
University of Southern Maine
USA

Stefano Bonassi

Head, Clinical and Molecular Epidemiology
IRCCS San Raffaele Pisana
Italy


Sara Frías Vázquez

Research Department of Human Genetics
National Institute of Pediatrics
Mexico

Rhian Cope

Principle Toxicologist
Toxicus
Australia

Brandon Jeffy

Principal Scientist
Exploratory Toxicology
Celgene Corporation
USA


Katya Tsaioun

Scientific Director
Safer Medicines Trust
USA

Rajendra Kumar Singh

Associate Toxicology Specialist
Health and Environmental Science
Dow Corning Corporation
USA

Jatinder Singh

Director & Head of Safety Assessment
Retrophin Inc
USA


Guillermo Eli Liwszyc

Physician, Researcher
Helsinki, Finland

Jatinder Singh

Director and Head,
Preclinical Safety,
Ariad Pharmaceuticals,
Cambridge MA, USA

In Press


Integrative Pharmacology, Toxicology and Genotoxicology discontinued as of 2018 and Continued as Global Pharmaceutical Research. We would like to express our sincere thanks to the authors, referees, and editors who contributed to the journal over past years.

Current Issue


Integrative Pharmacology, Toxicology and Genotoxicology discontinued as of 2018 and Continued as Global Pharmaceutical Research. We would like to express our sincere thanks to the authors, referees, and editors who contributed to the journal over past years.

Integrative Pharmacology, Toxicology and Genotoxicology is being discontinued as of 2016 and continued as Global Pharmaceutical Research. We would like to express our sincere thanks to the authors, referees, and editors who contributed to the journal over past years.


Archive

Volume 1

Announcing the   launching   of   Integrative   Pharmacology,Toxicology, and Genotoxicology

Marcelo L. Larramendy Ofelia A. Olivero

Editorial -Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

January 22 , 2015


Epigenetically mediatedtoxicity de-mystified: a confluence of pharmacology, genotoxicology and toxicology

Jatinder Singh

Editorial -Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

January 28, 2015


A-quantitative-comparison-of-intranasal-and-intratracheal-administration-of-coarse-PM-in-the-mouse

Angela Lee Linderholm Lisa M. Franzi Keith J. Bein Kent E Pinkerton Jerold A. Last

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

January 29, 2015


Some implication of environmental pesticides pollution on malaria control in Ghana

D. K. Essumang

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

February 14, 2015


Antioxidant and neuroprotective potential of extract of Brazilian pine Araucaria angustifolia bracts against oxidative stress induced by sodium azide in hippocampus of rats

Fernanda de Souza Machado Fernanda de Souza Machado Jonnsin Kuo Bárbara Roberta Ongaratti Niara da Silva Medeiros Mirian Salvador Caroline Dani Cláudia Funchal

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

February 20, 2015


Biomarkers of genotoxicity measured in human lymphocytes exposed to benzo[a]pyrene: Aneugenic effect, and involvement multiple primary DNA lesions

F. Fortin Y. Bonvalot T. C. V. Pham N. Ouellet Ayotte C. Viau N. Lemieux

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

February 22, 2015


Evaluation of genotoxicity of monocrotophos and quinalphos in rats and protective effects of melatonin

Vibhuti Mishra Sapneh Sharma Shilpa Khatri Nalini Srivastava

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

February 22, 2015


Amelioration of 5-FU induced toxicity by using RF under white light: An in vitro study

Eram Husain Sandesh Chibber Imrana Naseem

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

February 27, 2015


What do we know about stem cells and application in Pharmacology

Ramya K and Sankar P

Short Communication-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

March 23, 2015


Drug-seeking behaviours for codeine-acetaminophen and tramadol-acetaminophen prescriptions: a pilot study

Nevio Cimolai

Research Article -Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

March 23, 2015


Anti-acetylcholinesterasic, antioxidant and antibacterial activities of Juniperus brevifolia extracts

Nemésia Oliveira Sofia Medeiros José Silvino Rosa Ana M. L. Seca Maria Carmo Barreto

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

March 23, 2015


Development of mouse skin tumors by 7, 12- dimethylbenz (a) anthracene and its prevention by C-phycocyanin involve the regulators of cell cycle and apoptosis

Naresh Kumar Gupta Krishna P. Gupta

Research Article -Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

March 30, 2015


Enhanced haemagglutination and phytochemical evaluation suggest significant presence of glycoproteins (Lectins) in semi-purified fractions of eastern Nigeria Mistletoe, Loranthus micranthus Linn.

Edwin Ogechukwu Omeje Patience Ogoamaka Osadebe Ugwuoke Christopher Pamela Chinenye Akaraekwe

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

April 03, 2015


Endocrine disruption and cytotoxicity of Glyphosate and Roundup in human JAr cells in vitro

Fiona Young Dao Ho Danielle Glynn Vicki Edwards

Research Article-Integrative Pharmacology, Toxicology and Genotoxicology (IPTG)

April 04, 2015


Submit Manuscript


IPTG welcomes direct submissions of manuscripts from authors. You can submit your manuscript to: submissions@oatext.com

Publication Charges


Integrative Pharmacology, Toxicology and Genotoxicology is an Open Access journal and we do not charge the end user when accessing a manuscript or any article. This allows the scientific community to view, download, distribution of an article in any medium, provided that the original work is properly cited, under the term of "Creative Commons Attribution License". In line with other open access journals we provide a flat fee submission structure on the acceptance of a peer-reviewed article which covers in part the entirety of the publication pathway (the article processing charge). The process includes our maintenance, submission and peer review systems and international editing, publication and submission to global indexing and tracking organisations and archiving to allow instant access to the whole article and associated supplementary documents. We also have to ensure enough investment to secure a sustainable model which ethically, legally and financially stable.

The publication charges for Integrative Pharmacology, Toxicology and Genotoxicology are GBP 690.

Frequently Asked Questions (FAQs)

Why are your charges set at these levels?

All articles published in OA Text are open access. Open Access publishing implies that all readers, anywhere in the world, are allowed unrestricted to full text of articles, immediately on publication in OA Text Journals. The Article Publication Charges pay for the editorial and production costs of the journal, for hosting the website, publishing articles online, preparing HTML , PDF and XML versions of the articles and submitting the articles in electronic citation database like CrossRef.

Our financial goals are to:

  • Recover capitalization costs;
  • Produce sufficient revenue to allow for a sustainable and scalable publishing program, under continuous development;
  • Bend the publication-charge cost downward over time.

Who will pay the APC?

Corresponding author or Co-authors has to make the payment on acceptance of the article.

When should I pay?

Corresponding author or the paying institutions should arrange for the payment once they are notified regarding acceptance of the article. APC is exempted for cases in which a wavier agreement has been made in-prior to submission.

*We request an immediate attention towards the payment as the articles will not be published unless the charges have been paid.

How do I pay?

Authors or institutions can make payments by two modes as per their convenience.

  1. Wire/Bank transfer
  2. Card payment

Note: No taxes are included in this charge, taxes will be applicable as per the policies of the country of the payee. Additional transaction charges may be levied on the author.

Can I be eligible for wavier on APC?

The waiver request will be considered on a case-by-case basis, and will be provided accordingly.

*The Waiver requests must be made during the submission process and will not be accepted after  processing of the manuscript.

Do I have to pay if my manuscript is rejected?

No, Article processing charges will not be applicable for articles rejected by the Editorial office.

Withdrawal Charges

Are reprints of my article included in the article processing charges (APCs)?

No, Article processing charges (APCs) do not include the charges for the reprints. Reprints facility is optional and should be order separately.

Most Viewed

Place 5 articles ofarchive

Submit your Next Article

  • Online submission
  • Highly indexed and abstracted
  • 7 years of successful publishing
  • Wider visibility though open access
  • Higher impact with wider visibility
  • Prompt review